Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Randomized, Controlled Clinical Trial, Assessing the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease in Chinese Population With Coronary Heart Disease

NCT02946307 is registered in ClinicalTrials.gov with ZhuHai Cardionovum Medical Device Co., Ltd. as lead sponsor.

NCT NCT02946307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02946307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Randomized, Controlled Clinical Trial, Assessing the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease in Chinese Population With Coronary Heart Disease
Lead sponsor
ZhuHai Cardionovum Medical Device Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2016
Completion date
May 31, 2019
Enrollment
240 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stenosis